Cancer Family

Lymphocytic Neoplasm

HematologicNon-malignant3,036 active trials72 approved drugs345 evidence items

NCIt: C7065

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (380)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 151–175 of 380 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Cardiovascular Toxicity of Monoclonal Antibodies Approved for Multiple Myeloma: Evidence Based on FAERS Database.
Ting Liang, Junfeng Li, Cong Xu · Ther Innov Regul Sci · Sep 1, 2026 · PMID 42289016 · candidate dictionary pubmed
Prognostic factors for patients with relapsed or refractory multiple myeloma who are initiating a fourth or later line car T-cell or bispecific antibody therapy: a systematic literature review and meta-analysis.
Krina Patel, Ken Hasegawa, Jie Ting et al. · Expert Rev Hematol · Sep 1, 2026 · PMID 42269717 · candidate dictionary pubmed
Understanding and addressing resistance to IMiDs immunomodulatory compounds in multiple myeloma.
Maria-Cynthia Fuentes-Lacouture, Devi Nandana, Karthik Ramasamy et al. · FEBS J · Sep 1, 2026 · PMID 42165697 · candidate dictionary pubmed
Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial.
Lorenzo Falchi, Joost S P Vermaat, Joshua D Brody et al. · Lancet Haematol · Sep 1, 2026 · PMID 42660129 · candidate dictionary pubmed
A single-cell atlas of multiple myeloma defines malignant archetypes and proliferative states.
Mor Zada, Anna Kurilovich, Noam Shapira et al. · Nat Genet · Sep 1, 2026 · PMID 42680839 · candidate dictionary pubmed
A Multivariable Prediction Model for Early Mortality in Multiple Myeloma Patients With Renal Impairment.
Menghan Liu, Yuan Jian, Huixing Zhou et al. · Cancer Med · Sep 1, 2026 · PMID 42717545 · candidate dictionary pubmed

Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

Tzvika Porges, Tsofia Levi, Eldad J Dann et al. · Br J Haematol · Sep 1, 2026 · PMID 42448612 · candidate dictionary pubmed

Bone progression in multiple myeloma: Benefit of zoledronic acid for patients achieving at least Very Good Partial Response and prognostic value of bone turnover markers.

Michael Tveden Gundesen, Annette Juul Vangsted, Carsten Helleberg et al. · Br J Haematol · Sep 1, 2026 · PMID 42581608 · candidate dictionary pubmed

High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

Y Lisa Hwa, Dragan Jevremovic, Karen Pak et al. · Br J Haematol · Sep 1, 2026 · PMID 42543782 · candidate dictionary pubmed

Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.

Damian M Mikulski, Curtis Marcoux, Mark R Tanner et al. · Br J Haematol · Sep 1, 2026 · PMID 42494235 · candidate dictionary pubmed

Prognostic significance of dynamic minimal residual disease trajectories in newly diagnosed multiple myeloma.

Jiapei Yu, Qi Chen, Min Shi et al. · Br J Haematol · Sep 1, 2026 · PMID 42481078 · candidate dictionary pubmed

The development of novel chimeric antigen receptor gamma-delta T cells against multiple myeloma and single-cell RNA sequencing analysis.

Yang Hong, Cuiling Zhang, Jue Wang et al. · Br J Haematol · Sep 1, 2026 · PMID 42438316 · candidate dictionary pubmed

A Comparative Analysis of Multiple Myeloma Disease Burden in China and Globally From 1990 to 2023 and Future Trend Projections.

Fuhong Zhu, Huiting Wang · Cancer Med · Sep 1, 2026 · PMID 42740547 · candidate dictionary pubmed

Redefining second-line treatment strategy, sequencing, and real-world implementation in relapsed/refractory multiple myeloma: insights from the 31st Annual Congress of the European Hematology Association.

Ajai Chari, Peter M Voorhees, Raymond Thertulien · Clin Adv Hematol Oncol · Sep 1, 2026 · PMID 42748346 · candidate dictionary pubmed

Prognostic Significance of Peripheral Blood Neutrophil-To-Lymphocyte Ratio (NLR), Monocyte-To-Lymphocyte Ratio (MLR), and Platelet-To-Lymphocyte Ratio (PLR) in Patients With Multiple Myeloma: A Retrospective Cohort Study.

Lihong Zhang, Bing Ma, Jingyu Zhang · J Clin Lab Anal · Sep 1, 2026 · PMID 42608992 · candidate dictionary pubmed

Controversies in the Management of Early-Stage Hodgkin Lymphoma: The Role of Radiation Therapy.

Yorleny Vicioso Mora, Christopher R Kelsey · J Natl Compr Canc Netw · Sep 1, 2026 · PMID 42753815 · candidate dictionary pubmed

A Multicenter Retrospective Comparative Analysis of Therapeutic Outcomes in Multiple Myeloma Patients Receiving Varied Ixazomib Dosage Regimens.

Liang Zhao, Xiao He, Mingyang Deng et al. · Cancer Med · Sep 1, 2026 · PMID 42779200 · candidate dictionary pubmed

Assessing the Impact of Rituximab on Treatment Outcomes in Pediatric Advanced Mature B-Non Hodgkin Lymphoma - Authors' Reply.

Archana Sasi, Shuvadeep Ganguly, Sameer Bakhshi · Indian J Pediatr · Aug 31, 2026 · PMID 42671532 · candidate dictionary pubmed

Impact of Intensified Chemoimmunotherapy Regimens in Aggressive Non-Hodgkin Lymphoma on Reproduction Patterns.

Stefanie Antonilli, Anna Marklund, Joshua Entrop et al. · Eur J Haematol · Aug 25, 2026 · PMID 42639856 · candidate dictionary pubmed

Assessing the Impact of Rituximab on Treatment Outcomes in Pediatric Advanced Mature B-Non Hodgkin Lymphoma - Correspondence.

Xun Feng · Indian J Pediatr · Aug 22, 2026 · PMID 42631891 · candidate dictionary pubmed

Declining treatment-related and overall mortality in children with newly diagnosed advanced-stage non-Hodgkin lymphoma treated in a paediatric cancer centre during 2013-2024, Shanghai, China.

Xinyu Qiao, Yuejia Tang, Qiushi Yang et al. · Br J Haematol · Aug 21, 2026 · PMID 42629604 · candidate dictionary pubmed

Quantity Does Not Matter: Number, Ratio, or Grouping of Hodgkin/Reed-Sternberg Cells Does Not Affect Prognosis in Patients with Classic Hodgkin Lymphoma.

Burcin Pehlivanoglu, Nazimcan Tezel, Osman Can Ozturk et al. · Medicina (Kaunas) · Aug 17, 2026 · PMID 42654466 · candidate dictionary pubmed

Interim Positron Emission Tomography-Adapted Treatment Strategies for Classic Hodgkin Lymphoma: Insights From Korean Real-World Data.

Seonggyu Byeon, Ka-Won Kang, Kunye Kwak et al. · J Korean Med Sci · Aug 17, 2026 · PMID 42617191 · candidate dictionary pubmed

Morphologic mimicry of cutaneous T-cell lymphoma as classic Hodgkin lymphoma-a case report.

Julia Lunt, Rowan Burns, Christine Mg Schammel et al. · J Hematop · Aug 12, 2026 · PMID 42587213 · candidate dictionary pubmed

From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes.

Guluzar Gulnur Itez, Asuman Sunguroğlu · Ther Adv Hematol · Jan 1, 2026 · PMID 42699035 · candidate dictionary pubmed